visceral fat

Abdominal Fat Accumulation in HIV: Interview with Dr Grinspoon

Nelson Vergel from PowerUSA.org interviews Dr Steven Grinspoon from Harvard Medical School about what we know about HIV lipodystrophy associated fat accumulation. Dr Grinspoon covers potential causes and treatments. For more information please refer to the closing image at the end of the video. QUESTIONS FOR DR GRINSPOON’S INTERVIEW: 1. Please give our audience background …

Abdominal Fat Accumulation in HIV: Interview with Dr Grinspoon Read More »

Interview with Dr Gerald Pierone About HIV Lipodystrophy Options

Nelson Vergel, director of Program for Wellness Restoration, interviews Dr Pierone about his long experience treating patients with HIV facial lipoatrophy and his upcoming study for patients with HIV related abdominal fat accumulation. His website is www.FacialRejuvenationFL.com You can also ask him questions on TheBody.com. You can also find more info on PoWeR’s site www.FacialWasting.org …

Interview with Dr Gerald Pierone About HIV Lipodystrophy Options Read More »

Update on Egrifta for the reduction of visceral fat accumulation associated with HIV lpodystrophy

Serono launched Egrifta this month. Doctors are calling in the number included in the link below to get the paper work started for insurance reimbursement. It seems that some insurance companies are  already starting to pay for it, but high copays may be required. Serono has a $200 copay assistance per prescription. The total yearly …

Update on Egrifta for the reduction of visceral fat accumulation associated with HIV lpodystrophy Read More »

AIDS Activists Support the Approval of Egrifta- But With Some Conditions for Theratecnologies and Serono

17 May 2010 Paul Tran, BS Pharrn, RPh Advisors and Consultants Staff Center for Drug Evaluation and Research Food and Drug Administration 5630 Fishers Lane, HFD-21 Rockville, MD 20857 Dear Mr. Tran: On behalf ofthe Drug Development Committee (DDC) ofthe AIDS Treatment Activists Coalition (ATAC), I am writing to urge members ofthe Endocrinologic and Metabolic …

AIDS Activists Support the Approval of Egrifta- But With Some Conditions for Theratecnologies and Serono Read More »

Survey: Most patients with HIV lipodystrophy are willing to inject Egrifta once a day to reduce their visceral fat

 LIPODYSTROPHY TREATMENT- PATIENT ACCEPTANCE DownloadCreate Chart1. Has your belly fat increased after starting HIV medications? answered question 85 skipped question 2 Response Percent Response Count Yes 92.9% 79 No 7.1% 6 DownloadCreate Chart2. Would you be willing to inject a drug daily under your skin in your belly to decrease your belly fat by 13% …

Survey: Most patients with HIV lipodystrophy are willing to inject Egrifta once a day to reduce their visceral fat Read More »

Impact of Lipodystrophy on Quality of Life of People Living With HIV- Survey Results

1. How old are you? answered question 1,325 skipped question 6 ResponsePercent ResponseCount Under 15 years old 0.3% 4 15-20 0.2% 2 20-25 0.5% 7 25-30 1.7% 23 30-35 4.8% 63 35-40 7.8% 104 40-45 23.1% 306 45-50 22.6% 299 50-55 20.8% 275 55-60 11.4% 151 Over 60 6.9% 91 DownloadCreate Chart2. What is your …

Impact of Lipodystrophy on Quality of Life of People Living With HIV- Survey Results Read More »

FDA Committee Unanimously Recommends Egrifta for Lipodystrophy

FROM POZ.COM May 27, 2010 FDA Committee Unanimously Recommends Egrifta for Lipodystrophy A U.S. Food and Drug Administration (FDA) advisory committee has unanimously recommended that Egrifta (tesamorelin), Montreal-based Theratechnologies’ experimental product for the treatment of excess abdominal fat in HIV-positive people with lipodystrophy, be approved by the agency.  Though the FDA is not required to …

FDA Committee Unanimously Recommends Egrifta for Lipodystrophy Read More »